At first, it didn’t seem like much. In mid-October of 2025, my 33-year-old daughter, Lily, called to say that she’d been feeling short of breath. My first thoughts were asthma (she’d been diagnosed as a child, though she’d never needed to use her inhaler) or allergies, and later, as her symptoms progressed to include a persistent cough and tightness in her chest, maybe pneumonia or a blood clot (we’d recently returned from a family trip to Greece, and I knew that long flights could induce deep vein thrombosis in the leg, which might then migrate to the lung).
Her primary care doctor took an X-ray that didn’t reveal anything out of the ordinary, but a second X-ray, ordered by a pulmonologist a couple of weeks later, was shocking. It looked, to me, as if her lungs had been hung with iridescent strings. By that point, her heart rate was so elevated that she had to be admitted to the hospital before she could undergo a biopsy. A few days later, the biopsy revealed that my daughter—my healthy daughter who ate well and exercised regularly and had never smoked in her life—was suffering from stage IV lung cancer.
We got her transferred from a small community hospital in Brooklyn to Memorial Sloan Kettering in Manhattan, where her ability to breathe was so compromised that she had to be put on a ventilator in an induced coma. They didn’t tell us then, but her doctors were seriously worried that she was going to die. Gradually, they got her symptoms under control, in large part by administering a round of chemotherapy while she was still in the coma (something they were loath to do, but eventually felt was unavoidable). Her breathing slowly improved, and after two weeks, we were able to take her home with us to northern New Jersey to convalesce. She’d lost 30 pounds and needed a walker to make the trip from the curb to our front door.
A Global Epidemic
What was truly shocking about my daughter’s experience, though, wasn’t her diagnosis and its dire, precipitous effects, but the fact that she wasn’t an outlier. Worldwide, over the past 3 ½ decades, there’s been a dramatic increase in cancer diagnoses among people under 50—so dramatic that many oncologists are calling it an epidemic. A 2025 French study published in the journal ESMO Open, for instance, reported that between 1990 and 2019, the global incidence of these so-called early-onset cancers rose by 79.1 percent, with cancer mortality increasing by 27.7 percent.
Younger women have been hit disproportionately. The same study reported that, between 2002 and 2021, the number of cancer diagnoses among women under 50 grew by about 21 percent, while those among young men actually dropped slightly overall, though there were significant increases in the number of young men diagnosed with colorectal, kidney and testicular cancers, and leukemia.
Start Your Sunday Here
Sign up for the Gist newsletter and ease into your Sunday morning with our editor-selected top stories and can’t-miss reads—a perfect pairing with your first cup of coffee.
Like many of her peers, Dr. Maithili Rao, an oncologist and hematologist with Atlantic Medical Group Oncology & Hematology in Morristown, has witnessed the trend firsthand. “I’ve been in practice as an oncologist for 17 years and longer than that as a physician, and over that time, I’ve seen a significant increase in younger people with cancers. It’s really heartbreaking,” she says. Many of her patients with breast and colorectal cancer are in their twenties and thirties.
Diagnoses Delayed
The cancers most commonly seen in younger people are, in fact, breast and colorectal cancer, followed by kidney and uterine cancer, but other types are increasing as well, including pancreatic, testicular and three types of blood cancers; lung cancer is increasing among young women who’ve never smoked.
These cancers tend to be diagnosed at a later stage than similar cancers in people aged 50 and older, because cancer may well be the last thing on the mind of a primary care physician whose young patient reports, say, shortness of breath or rectal bleeding.
“If a 30-year-old walks into your office and says, ‘I’ve got rectal bleeding’—which is the most common sign of colorectal cancer—it’s still more likely to be hemorrhoids than anything else,” says Dr. Usman Shah, a gastrointestinal oncologist with the Summit Medical Group. In addition, notes Dr. Neil Morganstein, an oncologist and hematologist and Dr. Shah’s colleague who specializes in lung cancer and multiple myeloma, “a lot of younger people we deal with don’t have a primary care doctor, which means they don’t have immediate access to medical care.”
Jeremy Kaye did have a primary care doctor, who initially thought, at Kaye’s 2016 physical, that his patient’s swollen testicle might be the result of varicocele, an enlargement of veins within the scrotum. When the Cranford resident returned for his physical in 2017, the testicle had gotten significantly larger. At that point, Kaye’s doctor referred him to a urologist, who diagnosed him with testicular cancer. “It shattered my world,” Kaye says. He was 24 at the time.
The Same Cancer—But Different
Because so many early-onset cancers are diagnosed at a more advanced stage, says Dr. Shah, “the prognosis can be worse.” In fact, mortality rates are higher than average for early-onset colorectal, testicular and uterine cancer, though not necessarily for other types. It also appears that some early-onset cancers differ on a molecular level from the same cancers in an older population, which could contribute to higher mortality rates.
For the most part, the treatment younger cancer patients receive is the same as for their older counterparts, though, as Dr. Shah observes, “the difference is that younger patients are able to have more aggressive therapy because they can tolerate it more—they’re otherwise healthier.” So doctors may prescribe more chemotherapy sessions or a larger combination of chemotherapy drugs, which could improve outcomes. Dr. John Conti, an oncologist and hematologist with Regional Cancer Care Associates in Montclair and Belleville, notes that even though their cancers may be more aggressive, “younger patients often reach survival outcomes that are comparable to, or in some instances exceed, those seen in late-onset disease.” So while some early-onset cancers are more deadly due to diagnoses at a more advanced stage, others may be less so thanks to younger patients’ relative good health.
What’s distinctly different about cancer in people under age 50 is its emotional and practical effects. “These patients,” says Dr. Shah, “have unique needs. They’re in early- or mid-career; they have young families and responsibilities that patients in their 60s and 70s don’t normally have to grapple with.” When Kaye was diagnosed with testicular cancer at 24, his thoughts were less about his own mortality and more about, as he says, “what this was going to change from a relationship perspective and how it was going to affect my ability to have children.” In fact, oncologists are increasingly addressing their younger patients’ social and psychological needs alongside their medical demands.
Those needs may include financial support, child care, elder care and emotional support, ideally from peers who know what it feels like to be young and fighting cancer. Kaye notes that, when he was diagnosed, he felt very alone. He wasn’t aware, then, that there were organizations offering peer-to-peer support to young people diagnosed with cancer. Today, he serves on the board of trustees of one of them, Cancer Hope Network. As diagnoses of early-onset cancer have grown, similar networks have emerged, among them, Young Survivors Coalition and Stupid Cancer.
Searching for Causes
The great, and as yet unanswered, question regarding the increase in early-onset cancer is why it’s happening in the first place. Theories abound, most of them having to do with diet and environmental exposures. Dr. Rao notes that the rise in obesity may be one factor. “It might lead to chronic inflammation or dysregulate the immune system somehow,” she posits.
Certainly, our diets have changed dramatically over the past several decades, especially in more developed countries, where early-onset cancer is rising most sharply. We’re eating more ultra-processed foods, more sugar, and less fiber than our grandparents did. Dr. Rao observes that “eating whole foods, lowering sugar intake, eating less red meat, and increasing the consumption of fiber and fresh fruits and vegetables has been associated with a lower risk of colorectal cancer.” It would be a reasonable assumption, then, that doing the opposite might raise that risk.
—Dr. Maithli Rao, oncologist and hematologist in Morristown
I’ve been in practice as an oncologist for 17 years, and longer than that as a physician, and over that time I’ve seen a significant increase in younger people with cancers. It’s really heartbreaking.
Antibiotic exposure, especially in childhood, is also a potential culprit. As helpful as they are in fighting bacterial diseases, antibiotics, Dr. Shah notes, can cause dysbiosis—an imbalance of the good and bad bacteria that make up the gut microbiome—which can lead to inflammation. “We think that an increase in inflammatory bacteria in the gut,” he says, “can ultimately lead to cancer 10 or 20 years later.”
Many oncologists suspect that our increasing use of pesticides could play a role as well. A 2026 study out of the University of Southern California, for instance, reached a startling conclusion: Young people who ate a diet rich in whole grains and fresh fruits and vegetables seemed to have an elevated risk of lung cancer. Though researchers couldn’t explain precisely why, they theorized that those healthy foods could be delivering not just nutrients, but pesticides as well. And beyond pesticides, Dr. Rao observes, “there’s clearly been an increase in chemicals in the environment, as well as microplastics and air pollution,” all of which could be contributing to early-onset cancer.
Is Screening the Answer?
When my daughter was diagnosed with lung cancer, one of my first thoughts was that screening might well have caught it at an operable, potentially curable stage. This would have been true for most younger people diagnosed with lung and other cancers. John Allen, an attorney in Hoboken who, until 2026, served in the New Jersey Legislature, was diagnosed a year ago with colorectal cancer at the age of 42, after his primary care doctor did routine blood work and noticed a precipitous drop in his iron level. Currently, the recommended age to start screening for colorectal cancer with a colonoscopy is 45. But, as Allen’s doctor observed, “if you’d waited until you were 45, you’d be a goner.”
But because virtually all tests used to screen for cancer carry potential risks and are expensive, it’s impractical to lower recommended screening ages beyond a certain point. Dr. Ahmed Al-Khazraji, an assistant professor of gastroenterology at Rutgers New Jersey Medical School and coauthor of a recent study of early-onset colorectal cancer, notes that “our findings support the current emphasis on beginning average-risk screening for colorectal cancer at age 45, and 40 in African Americans, but they also raise concern that this may not capture the increasing burden among adults aged 20 to 44 years.”
At present, though, he cautions, “there isn’t enough evidence to recommend universal screening before age 45.” It should be noted that, until 2021, the recommended age for a first colonoscopy was 50; that changed when colorectal cancer began to proliferate in people as young as 45. It’s possible that, if the number of early-onset cancers continues to grow, screening ages might be adjusted down—though it’s an outcome contingent on a change no one would wish for.
If there’s any good news about what’s otherwise a deeply distressing trend, it’s that cancer research is yielding treatments that promise to change outcomes for a wide variety of cancer patients. Especially promising are the drugs that target mutations that fuel certain cancers. My daughter’s oncologist, for instance, was able to identify the mutation supporting her lung cancer, and she’s now taking a daily pill that, we hope, will continue destroying the blood vessels sustaining her tumors, keeping her cancer at bay for years to come.
In fact, many of those diagnosed with early-onset cancers are living productive, happy lives and hope to continue to do so with the help of what often seem like medical miracles. Sometimes, though, miracles are less important than simple acts of self-care, like having a primary-care doctor and getting regular checkups, as Allen did. His colorectal cancer was caught early enough that he’s now considered cancer free.
The diagnosis changed him, he says, but some of those changes were for the better. “I like to think I live with more purpose and more joy,” he says. “After you hear that diagnosis, the sun hits your face very differently.”
